Skip to main content
. 2022 Sep 30;12(19):3427. doi: 10.3390/nano12193427

Figure 8.

Figure 8

(A) Anti-tumor pathway of CK/tLyp-1 liposome. (B) In vivo process of CK/tLyp-1 liposome and its active targeting. (C) A549 treated with CK/tLyp-1 liposome shows higher apoptotic rate. (D) In vivo measurement of tumor volume. Reprinted with permission from Ref. [126]. 2018, Taylor & Francis Online.